FDA Raises Concerns About Probiotic Products Sold for Use in Hospitalized Preterm Infants

Warning Letters Issued to Two Companies for Illegally Selling Probiotic Products to Treat Diseases in Preterm Infants SILVER SPRING, Md., Oct. 26, 2023 /PRNewswire/ — As part of the U.S. Food and Drug Administration’s commitment to protecting public health, the agency is advising the…